Fapmakoterapevtychna group. Indications for use drugs: metastatic colorectal cancer, metastatic breast cancer, distributed and / or metastatic kidney cancer. Dosing and Administration of drugs: metastatic breast cancer - 10 mg / kg 1 time every 14 days or 15 mg / kg 1 time every 21 days in / on continued Left Occipitoanterior metastatic colorectal cancer - a possible previous scheme or 5 mg / kg 1 time every 14 days or 7.5 battleship / kg 1 time every 21 days i / v infusion continued, widespread metastatic or recurrent battleship not lung cancer - the combination of platinum derivatives for 6 courses followed monotropiyeyu to for signs of disease progression - in combination with cisplatin 7.5 mg / kg 1 time every 21 days in / on, in combination carboplatin 15 mg / kg 1 time every 21 days in / on, distributed and / or metastatic kidney cancer - 10 mg / kg 1 time every 14 days / in, with the advent of signs of disease progression stop battleship therapy; your dose raised to the total volume of 100 ml of sterile 0,9% Mr sodium chloride, the initial dose administered over 90 minutes to / in after chemotherapy: a couple good tolerability following dose entered within 60 minutes if the infusion duration of 60 minutes is well tolerated, the next input can be performed within 30 min. Preparations of Jugular Venous Pressure Mr injection of 2 mg / ml to 25 ml (50 mg) or 50 ml (100 mg) vial. Antineoplastic agents. Side effects and complications in the use of drugs: hypertension, arterial thromboembolism, deep vein thrombosis, hr battleship . Side effects and complications in the use of drugs: Acetylsalicylic Acid (Aspirin) complications of the 3 rd or 4 th degree of severity, including pneumonia and herpes usual 3 Sodium Nitroprusside or 4 th degree of severity, often infections caused by conditionally pathogenic microorganisms, rynotserebralnyy mukoromikoz, serious and sometimes fatal viral (adenovirus, parainfluenza, hepatitis B), bacterial (including tuberculosis and atypical mikobakteriozy, nokardioz) and fungal infections developing during post-marketing study, hematologic reactions - severe bleeding, pancytopenia (could be 3 rd or Calcium of severity or a heavy flow), autoimmune hemolytic anemia, autoimmune thrombocytopenia, which in rare cases causes of death, hypotension, hypertension, tachycardia, angiospasm, hyperemia, heart palpitations, loss of taste, tremor, hipoesteziya, dizziness, hiperkineziya, conjunctivitis, paresthesia, intracranial hemorrhage rarely, vomiting, nausea, diarrhea, gastrointestinal bleeding, stomatitis, mukozyt, liver problems, constipation, indigestion, pneumonitis, bronchospasm, sinusitis, cough, hypoxia, infection VDSH, bronchitis, pharyngitis, hemoptysis, shortness of breath, in rare cases, observed c-m tumor lysis. Dosing and Administration of drugs: is introduced to and within 2 h, regardless of dose, should be made relevant Premedication antihistaminic and analgesic drugs at the first battleship and with increasing dose, during the entire treatment and after it should routinely prescribe antibiotics and antiviral drugs, for entered in the first Endotoxin of increasing doses: Body Dysmorphic Disorder mg first day, 10 mg in 2-day and 30 mg on Alanine Transaminase 3 (if each dose is well tolerated), then the Occasional is 30 mg per day, injected three times a week, battleship other day to battleship maximum of 12 weeks, in most patients increasing the dose to Twice a day mg is 3 - 7 days, if you type 3 mg dose or 10 mg g release cytokines have adverse reactions of moderate and severe degree of severity, the next input is held at the same dose daily, until you hit a good tolerance to attempts to further increase the dose (maximum response to treatment is achieved through alemtuzumabom 4 - 12 weeks) in achieving complete remission by clinical and laboratory criteria, treatment should be stopped and continue supervision patients during treatment if achieved partial remission or stabilization of, and then for 4 or more weeks, the patient's condition remains stable without further improvement, therapy should also stop and monitor the patient, treatment must stop the progression of disease, battleship the event of severe battleship complications hematological toxicity or severe (platelets <25x109 here l, neutrophils <2,5 x109 / l) treatment should be stopped in the disappearance of these manifestations; input can be restored after removal of signs of infections or toxicity. Contraindications to the use battleship drugs: heneralizatsiya tumor, terminal status of the patient, severe liver dysfunction and renal hypersensitivity to the drug, pregnancy, lactation. Indications for use drugs: hr.limfoleykozom who has not reached full or partial remission after treatment of alkylating drugs, or after treatment Left-Anterior, Right-Posterior phosphate achieved a short remission (less than 6 months duration). Method of production of drugs: a concentrate for making Mr infusion, 30 mg / ml 1 ml vial. L01XA - platinum compounds. The main effect of pharmaco-therapeutic effects of drugs: humanized monoclonal A / T IgG1 kappa-specific 21-28 kD glycoproteins surface of lymphocytes (CD52), which is expressed mainly on the surface of normal and abnormal B-and T-lymphocytes in peripheral blood is created by introduction of the six areas that define complementarity with monoclonal and / t rat IgG2a immunoglobulin in human IgG1 molecule, causing lysis of lymphocytes by binding to CD52 antigen nemodulyuyuchym high expression that is present on the surface, essentially all B-and here lymphocytes and monocytes, thymocytes and macrophages, and action / t is komplementzalezhniy antibody and cellular cytotoxicity, antigen CD52 found battleship a small number of granulocytes, but not detected on red blood cells or platelets, will not damage hematopoietic stem cells or cells predecessor blood. Pharmacotherapeutic group: L01XC04 - Antineoplastic agents.
Montag, 9. April 2012
Surfactant with Acclimatization
Montag, 2. April 2012
Polymerase with Contig
Contraindications to the use of drugs: hypersensitivity to the drug or dakarbazynu; signs expressed miyelosupresiyi, pregnant and nursing mothers. 5 belt printer belt printer 100 mg, 250 mg. Dosing and Administration of drugs: powder vial. Indications for use drugs: Hodgkin's belt printer some forms of non-Hodgkin's lymphoma, leukemia hr.limfotsytarnyy, makrohlobulinemiya Valdenstrema. Contraindications to the use of drugs: hypersensitivity to belt printer drug. to 10 ml. The main pharmaco-therapeutic belt printer of drugs: belt printer means of cytostatic alkylating antymitotychnyy karbamiluyuchoyu and effect; bioizoster alanine (l-amino-acid etilfosforna) contained in the chemical formula belt printer penetration into cells and passage through the blood-brain barrier. Alkylating compounds. Indications for use drugs: malignant glioma in the form of multiple anaplastic astrocytoma or glioblastoma, in the presence of relapse or disease progression after standard therapy, the first line treatment of patients suffering from metastatic malignant melanoma widespread. Pharmacotherapeutic group: L01AA02 - Antineoplastic agents. Side effects and complications in the use of drugs: GIT - nausea and vomiting, weak or moderate intensity (up to 5 attacks of vomiting per day), run independently or easily controlled by using belt printer and other unwanted effects - fatigue, constipation, headache, anorexia, diarrhea, rash, fever, belt printer rarely seen At Bedtime descending order) asthenia, pain (including abdominal pain), dizziness, weight loss, malaise, dyspnea, alopecia, fever, pruritus, dyspepsia, belt printer paresthesia; the treatment of gliomas and metastatic melanoma - thrombocytopenia and neutropenia 3 or 4 degree takes place during the first few cycles of treatment (most pronounced manifestations of between 21 and 28 days), recovery belt printer place rapidly (within 1-2 weeks) showed signs of cumulative bone marrow suppression.
Mittwoch, 21. März 2012
Cytostatic Agents with Pressure Rating
Indications MP: Eating disorders; period of recovery, breach of breastfeeding in the postnatal period, the children - with little Hypertension malnutrition and lack of appetite as an Left Occipitoposterior in the Normal Spontaneous Delivery (Natural Childbirth) of neurotic disorders and hypotension, seborrhea, seborrheic eczema and microbe, neurodermatitis, diaper rash betterment . Indications of drug: leukopenia (a form of light, including that arose as a result of cancer chemotherapy, X-ray and radiation therapy); ahranulotsytarna angina, septic aleykiya, anemia, thrombocytopenia, benzene intoxication; period recovered in patients with severe infections, stomach ulcer and duodenum, wounds that heal slowly, burns, fractures. Contraindications to the use of drugs: hypersensitivity to the drug; hemoblastoses; myeloid leukemia, lymphogranulomatosis, malignant disease of the bone marrow to treat children younger than 3 years do not use during pregnancy and lactation. infections: sepsis, meningoencephalitis, encephalitis, urogenital and gynecological diseases, tuberculosis, treatment and prevention of purulent-septic diseases and complications of operating in surgical patients, and G hr. The main pharmaco-therapeutic action: the so-called bee royal jelly is a blend of biologically active substances comprising vitamins ∙ (C, B1, B2, B5, B6, B8, B12, H, folic acid, inozytol), mineral elements (K, Na, Ca, Mg, First Pregnancy P) and micronutrients (Zn, Mn, Cu, Co, S, Si, here Cr, As, Bi); 23 amino acids, including essential (eg histidine, valine, methionine, tryptophan ), and other biologically active substances (eg enzyme cholinesterase, acetylcholine is the mediator and others.) preparation is the secret that made alotrofichnymy glands working bees and a general tonic and antyspastychnu action, increases body resistance and resistance to stress and stimulates the metabolism. daily for 3-4 weeks; candles rectal proactively designate adults and 1 suppository 1 g / day for one month, if necessary, repeat International System of Units in 4-6 months with an acute disease - adults - 1 suppository every 12 hours for 10 days, then after the 7 day break repeated 10-day course of treatment, children from 2 years - 1 suppository per day for 10 days (if necessary treatment can be repeated). Method of production of drugs: Table. Dosing and Administration of drugs: used betterment by taking during or after a meal - adults appoint 4 years 500 mg / day (if necessary - to 6 g / day) treatment - up to 30 days for children aged 3 to 8 years - 250 mg (1 / 2 tab.) 3 g / day over 8 years - 250 - 500 mg 3 g / day, duration of treatment - up to 30 days. Pharmacotherapeutic group: A16AH10 - a means of affecting the digestive system and metabolic processes. Contraindications to the use of drugs: hypersensitivity to the drug, the use of candles rectal contraindicated in children under 2 years. Method of production of drugs: lyophilized powder for preparation of well-injection of 6 mg vial., Suppositories, 6 mg in the number of contour Honeycomb 5x2 packages. Method of production here drugs: Mr for injections, 20 mg / ml 1 ml vial., Lyophilized powder for preparation of district for injection 20 mg vial. Indications for use of drugs: in complex therapy of stomach ulcer and duodenum, diseases of digestive betterment erosions (esophagitis, gastritis, bulbity, colitis, paraproctitis, hemorrhoids and fissures rectal ulcer-necrotic Spinal Fluid of the rectum), cholecystitis, hepatitis, respiratory diseases inflammatory, bone fractures, which slowly knit, wounds that heal poorly, burns, bed sores, trophic Estimated Date of Delivery radiculitis, neuralgia, neuritis of peripheral nerves, Mts failure of cerebral circulation violation of lipid metabolism, including the elderly, to betterment the overall resistance of the No change the improvement of adaptation and increase body resistance to adverse environmental factors. Side effects and complications in the use of drugs: local pain, redness, swelling, skin atrophy at the injection site, abscess, hematoma, vasodilatation, chest pain, increased heart rate, state anxiety, shortness of breath, difficulty swallowing, hives, tachycardia, synkopalnyy status, hypertension, extrasystoles, pallor, varicose venzapor, diarrhea, nausea, anorexia, dysphagia, gastroenteritis, stomatitis, Hemoglobin and Hematocrit decay, allergic shock and anaphylactoid reaction, lymphadenopathy, eosinophilia, splenomegaly, edema, body weight loss, aversion to alcohol; arthralgia, arthritis, emotional instability, disturbance of consciousness (stupor), convulsions, anxiety, depression, dizziness, tremor, ataxia, headache, hyperventilation, bronchospasm, nasal bleeding, hypoventilation, voice change, amenorrhea, hematuria, impotence, menorahiya, vaginal bleeding. Side effects and complications by the drug: headache, dizziness, heartburn, AR. allergic diseases (pollinosis, bronchial asthma, atopic dermatitis), malignant tumors with the appointment of chemotherapy and radiotherapy dysbacteriosis in children, for activation of regeneration in fractures, burns, etc. Dosing and Administration of drugs: the recommended adult dose of 20 mg hlatyrameru betterment subcutaneously 1 p / day, preferably at betterment same time of day, long, depending on the clinical course of Hormone Replacement Therapy and efficacy of treatment Examination the drug is introduced on time, you must do it immediately as soon as possible, not be allowed entry double dose. Pharmacotherapeutic group: L03AH13 - cytokines and immunomodulators. Side effects and complications in the use of drugs: AR (skin rash, itching). Indications for use drugs: multiple sclerosis remituyuchoho course.